For instance, Pexastimogene Devacirepvec (Pexa Vec), as an newly discovered OV [59, 60], has shown the ability to activate natural killer (NK) cells as well as CD4+ and CD8+ T cells within tumor tissues. Here, CD8A is linked to neoplasm.